EGFR and colorectal carcinoma: Both cleavable JANX008 TRACTr and the non-masked construct induced complete eradication of HCT116 colorectal (CRC) tumors in mice, although the TRACTr exhibited enhanced safety and pharmacokinetic properties relative to the EGFR-TCE in NHP.